Please try another search
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Name | Age | Since | Title |
---|---|---|---|
Michael F. Brigham | 60 | 1991 | President, CEO, Principal Financial Officer, Treasurer, Secretary & Director |
Bobbi Jo Brockmann | 45 | 2015 | VP of Sales & Marketing and Director |
Paul R. Wainman | 58 | 2014 | Independent Director |
Gloria J. Basse | 63 | 2020 | Independent Director |
Steven T. Rosgen | 57 | 2018 | Independent Director |
David S. Tomsche | 67 | 2006 | Independent Chairman of the Board |
Bryan K. Gathagan | 56 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review